Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

HAMAMATSU PHOTONICS

Hamamatsu Photonics develops, manufactures and markets optical sensors, photodiodes, photo ICs, image sensors and oth... read more Featured Products: More products

Download Mobile App




Infrared Signature for Mobile Phone Detects Malaria

By LabMedica International staff writers
Posted on 13 Dec 2022

Optical microscopy, rapid diagnostic tests (RDTs) and molecular tests are the three main diagnostic techniques currently available for malaria diagnosis. More...

Microscopy is the traditional way of detecting malaria parasites in stained thick or thin peripheral blood films using Giemsa, Wrights or Fields stains.

RDTs detect malaria antigens in blood by targeting falciparum-specific protein such as histidine-rich protein II (HRP-II) or lactate dehydrogenase (LDH). RDTs are simple, relatively cheap and can be used in remote areas without specialized equipment or need for electricity. However, RDTs can only reliably detect 50-100 parasites/ µL. Molecular tests such as polymerase chain reaction (PCR) are currently the most accurate and the most sensitive techniques for detecting malaria in low or sub-microscopic samples, for mixed infections and for differentiating Plasmodium species.

An international team of Tropical Medicine Specialists aided by those at The University of Queensland (Brisbane, Australia) hypothesized that the presence of malaria parasites in red blood cells produce unique infrared signatures that could potentially be used for malaria detection. They used a handheld near infrared spectrometer reflective (NIRS) model to non-invasively collect spectral signatures from the right and left ears, arms and fingers of malaria positive and negative individuals living in a malaria endemic area in Brazil where both P. falciparum and P. vivax are prevalent at a 30%/70% ratio. A total of 60 patients were scanned and a total of 360 spectra were collected. The infection status and Plasmodium species type were confirmed by microscopy and standard PCR.

The scientists uses the NIRvascan NIRS model G1 (Allied Scientific Pro, Gatineau, QC . Canada). The model used is a diffuse reflectance spectrometer with wavelength ranging from 900-1700nm, a 5000:1 signal to noise ratio and an optical resolution of 10nm pixel resolution. It has an inGaAs detector (Hamamatsu Photonics, Herrsching Germany), and it weighs 136g and measures 82.2 × 63× 40 mm, it is rechargeable and can be operated by either a computer or a smart-phone via Bluetooth.

The investigators reported that results from PCR confirmed 27/60 (45%) people scanned were positive with malaria while the rest were malaria negative. Of the malaria positive individuals, 75% (N=20) and 25% (N=7), were infected with P. vivax and P. falciparum, respectively. Results from microscopy indicated that out of the 27 infected patients, 7.4% (two subjects) had extremely high parasitaemia, 18.5% (five subjects) had moderate parasitaemia, 44.4% (12 subjects) had low parasitaemia and 29.6% (eight subjects) had very low parasitaemia.

Spectra collected from the ear produced the most accurate prediction of infection in the independent subjects with an accuracy of 92% (N=24), sensitivity of 100% (N=11) and specificity of 85% (N=13). Comparatively, the accuracy, sensitivity and specificity of the spectra collected from the finger was 70% (N=24), 72 (N=11) and 69% (N=13), respectively whereas spectra of the arm resulted into a predictive accuracy of 72% (N=24), sensitivity of 59% (N=11) and specificity of 85% (N=13).

The authors concluded that their proof-of-concept study provides insights on the potential application of NIRS and machine learning techniques for rapid, non-invasive and large-scale surveillance of malaria and potentially other human pathogens. The study was published on December 7, 2022 in the journal PNAS Nexus.

Related Links:
The University of Queensland 
Allied Scientific Pro
Hamamatsu Photonics


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Legionella Pneumophila Test
CHORUS Legionella Urinary Antigen
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.